Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Greenwich LifeSciences, Inc. (GLSI)
|
Add to portfolio |
|
|
|
| Price: |
$24.65
| | Metrics |
| OS: |
12.8
|
M
| |
|
|
| Market cap: |
$317
|
M
| |
|
|
|
Net cash:
|
$10.9
|
M
| |
$0.85
|
per share
|
|
EV:
|
$306
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($8.0)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Research and development | 6.5 | 3.6 | 1.1 | 2.6 | 1.3 |
| General and administrative | 1.6 | 1.0 | 0.8 | 0.8 | 0.4 |
| EBITA | -8.0 | -4.6 | -1.9 | -3.4 | -1.7 |
| Amortization of intangibles | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBIT | -8.0 | -4.6 | -1.9 | -3.4 | -1.7 |
| Pre-tax income | -7.8 | -4.6 | -1.9 | -3.4 | -1.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -7.8 | -4.6 | -1.9 | -3.4 | -1.7 |
| |
| Diluted EPS | ($0.61) | ($0.35) | ($0.20) | ($1.52) | ($8.32) |
| Shares outstanding (diluted) | 12.8 | 13.1 | 9.5 | 2.3 | 0.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|